share_log

Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco

Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco

Genvor将参加在旧金山举行的世界农业技术创新峰会
Accesswire ·  02/27 08:31

Genvor Presenting as a Featured Startup at Leading Global AgTech Event

Genvor作为特色初创公司亮相全球领先的农业科技盛会

CHAPEL HILL, NC / ACCESSWIRE / February 27, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of sustainable plant health solutions leveraging patented peptides, today announced that management will attend and present as a Featured Startup at the World Agri-Tech Innovation Summit taking place March 19-20, 2024 in San Francisco.

北卡罗来纳州教堂山/ACCESSWIRE/2024 年 2 月 27 日/ Genvor 公司 (OTCQB: GNVR)(“Genvor” 或 “公司”)是利用专利肽开发可持续植物健康解决方案的开发商,今天宣布,管理层将作为特色初创公司出席并出席会议 世界农业技术创新峰会 将于 2024 年 3 月 19 日至 20 日在旧金山举行。

World Agri-Tech brings together over 2,500 decision-makers among agri-food business, OEMs, food brands, growers, tech providers and investors for two days of high-level networking, strategic market intelligence and start-up discovery. With a focus on harnessing nature-based solutions to meet climate commitments, and successful paths for commercializing biological inputs, next-generation breeding, AI and automation, an outstanding speaking faculty uncovers the innovations and investment propelling new value creation in this sector.

World Agri-Tech汇集了来自农业食品企业、原始设备制造商、食品品牌、种植者、科技提供商和投资者的2,500多名决策者,进行为期两天的高层交流、战略市场情报和初创企业发现。一位杰出的演讲教师专注于利用基于自然的解决方案来履行气候承诺,以及实现生物投入、下一代育种、人工智能和自动化的成功途径,他们发现了推动该领域新价值创造的创新和投资。

Chad Pawlak, Chief Executive Officer of Genvor, plans to participate in one-on-one meetings with industry participants, investors and the media throughout the conference, and will give a presentation to attendees as a Featured Startup.

Genvor首席执行官查德·帕拉克计划在整个会议期间参加与行业参与者、投资者和媒体的一对一会议,并将作为特色初创公司向与会者发表演讲。

World Agri-Tech Innovation Summit: Featured Startup Presentation
Date: March 19-20, 2024
Location: Marriott Marquis| San Francisco, California

世界农业技术创新峰会:初创企业精选演讲
日期:2024 年 3 月 19 日至 20 日
地点:马奎斯万豪酒店 | 加利福尼亚州旧金山

For more information or to register for the event, please visit the conference website. To schedule a one-on-one meeting at the conference, please email your request to GNVR@mzgroup.us or call Lucas Zimmerman at (949) 259-4987.

欲了解更多信息或报名参加此次活动,请访问 会议网站。要在会议上安排一对一的会议,请将您的请求通过电子邮件发送至 GNVR@mzgroup.us 或致电 (949) 259-4987 致电卢卡斯·齐默尔曼。

About Genvor

关于 Genvor

Genvor Incorporated (OTCQB:GNVR) is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through next-generation biological foliar application as well as transgenic seed traits. Supported by globally renowned scientists and a USDA partnership, Genvor leverages its licensing-first business model with active trait developments underway for a variety of crops including corn, citrus, rice, cotton, soybean, flax, and potato. To learn more, please visit or follow us on LinkedIn, Facebook or Instagram.

Genvor 公司 (OTCQB: GNVR) 是可持续植物健康解决方案的开发商,其专利肽产品组合可通过下一代生物叶面应用和转基因种子性状为作物提供抗病原体和增强的营养特性。在全球知名科学家和美国农业部合作伙伴关系的支持下,Genvor利用其许可优先的商业模式,正在积极开发包括玉米、柑橘、水稻、棉花、大豆、亚麻和马铃薯在内的各种作物的性状。要了解更多信息,请访问 或者关注我们 领英Facebook 要么 Instagram

Forward-Looking Statements

前瞻性陈述

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include information about management's view of the Company's future expectations, plans and prospects, including future business opportunities or strategies and are generally preceded by words such as "may," "believe," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of known and unknown risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Certain of these risk factors and others are included in documents the Company files with the Securities and Exchange Commission, including but not limited to, the Company's Annual Report on Form 10-K, as well as subsequent reports filed with the Securities and Exchange Commission.

本新闻稿可能包含1933年《证券法》第27A条和1934年《证券交易法》第21E条所指的前瞻性陈述。前瞻性陈述包括有关管理层对公司未来预期、计划和前景的看法的信息,包括未来的商业机会或战略,前面通常以 “可能”、“相信”、“未来”、“计划” 或 “计划”、“将” 或 “应该”、“预期”、“预期”、“最终” 或 “预测” 等词语开头。请注意,此类陈述存在许多已知和未知的风险和不确定性,这些风险和不确定性可能导致未来的情况、事件或结果与前瞻性陈述中的预测存在重大差异,包括由于各种因素,实际业绩可能与前瞻性陈述中的预测存在重大差异的风险。其中某些风险因素和其他风险因素包含在公司向美国证券交易委员会提交的文件中,包括但不限于公司的10-K表年度报告以及随后向美国证券交易委员会提交的报告。

Investor Relations Contact:

投资者关系联系人:

Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
GNVR@mzgroup.us

卢卡斯·A·齐默尔曼
董事总经理
MZ 集团-MZ 北美
(949) 259-4987
GNVR@mzgroup.us

SOURCE: Genvor Incorporated

来源:Genvor 公司


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发